Table 3 The relationship between the expression of BCL-2, BAD and the histologic grade, clinical TNM stages and the axillary lymph nodes metastasis in youth and menopause breast cancer tissues

Youth breast cancer tissues

40

8

27

5

6

25

8

1

19

21

BCL-2+

19

7

12

0

4

12

3

0

3

16

BCL-2-

21

1

15

5

2

13

5

1

16

5

+%

47.5%

87.5%¹

44.4%

0.0%

66.7%³

48.0%

37.5%

0.0%

15.8%⁴

76..2%

BAD+

12

4

8

0

2

8

2

0

6

6

BAD-

28

4

19

5

4

17

6

1

13

15

+%

30.0%

50.0%²

29.6%

0.0%

33.3%³

32.0%

25.0%

0.0%

31.6%⁵

28.6%

Menopause breast cancer tissues

40

18

19

3

5

22

11

2

10

30

BCL-2+

30

16

14

0

4

17

8

1

2

28

BCL-2-

10

2

5

3

1

5

3

1

8

2

+%

75.0%

88.9%²

73.7%

0.0%

80.0%³

77.3%

72.7%

50.0%

20.0%⁴

93.3%

BAD+

25

11

13

1

4

15

6

0

5

20

BAD-

15

7

6

2

1

7

5

2

5

10

+%

62.5%

61.1%²

68.4%

33.3%

80.0%³

68.2%

54.5%

0.0%

50.0%⁵

66.7%